Amneal Pharmaceuticals (AMRX) announced the U.S. launch of Boruzu, a new presentation of bortezomib for ready-to-use subcutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback